-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Lb Pharmaceuticals Inc quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2024 to Q3 2025.
- Lb Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)